Advances in Nanostructures for Antimicrobial Therapy

Microbial infections caused by a variety of drug-resistant microorganisms are more common, but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic administration capable of acting against these resistant infectious pathogens. Formulation innovations of existing drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Jampilek, Josef, Kralova, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999898/
https://www.ncbi.nlm.nih.gov/pubmed/35407720
http://dx.doi.org/10.3390/ma15072388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999898/
https://www.ncbi.nlm.nih.gov/pubmed/35407720
http://dx.doi.org/10.3390/ma15072388

Ejemplares similares